News
Amryt and Medison Pharma Ltd sign distribution agreement for Myalept in Canada.
Amryt announces the signing of a distribution agreement with Medison Pharma Canada (“Medison”) to distribute Myalept (metreleptin) in Canada. This agreement completes the multi-regional distribution agreements with Medison, announced in February, to distribute Myalept (metreleptin) and Lojuxta (lomitapide) in Israel, and Juxtapid (lomitapide) in Canada.
This agreement completes the multi-regional distribution agreements with Medison, announced in February, to distribute Myalept (metreleptin) and Lojuxta (lomitapide) in Israel, and Juxtapid (lomitapide) in Canada.
Condition: Lipodystrophy
Type: drug
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.